These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37256791)

  • 21. Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration.
    Guerrini G; Gioria S; Sauer AV; Lucchesi S; Montagnani F; Pastore G; Ciabattini A; Medaglini D; Calzolai L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists.
    Stavnsbjerg C; Christensen E; Münter R; Henriksen JR; Fach M; Parhamifar L; Christensen C; Kjaer A; Hansen AE; Andresen TL
    J Control Release; 2022 Feb; 342():337-344. PubMed ID: 34973307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y; Shimizu T; Abu Lila AS; Ishida T; Kiwada H
    Biol Pharm Bull; 2015; 38(3):417-24. PubMed ID: 25757923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species.
    Li C; Cao J; Wang Y; Zhao X; Deng C; Wei N; Yang J; Cui J
    J Pharm Sci; 2012 Oct; 101(10):3864-76. PubMed ID: 22777607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Maleimide-Terminally Modified PEGylated Liposome Induced the Accelerated Blood Clearance Independent of the Production of Anti-PEG IgM Antibodies.
    Ishima Y; Yamazaki N; Chuang VTG; Shimizu T; Ando H; Ishida T
    Biol Pharm Bull; 2022; 45(10):1518-1524. PubMed ID: 36184510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
    Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
    Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
    Abu Lila AS; Ichihara M; Shimizu T; Ishida T; Kiwada H
    Biol Pharm Bull; 2013; 36(11):1842-8. PubMed ID: 24189428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes.
    Shimizu T; Lila ASA; Kitayama Y; Abe R; Takata H; Ando H; Ishima Y; Ishida T
    Biol Pharm Bull; 2024; 47(2):469-477. PubMed ID: 38383000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.
    Emam SE; Elsadek NE; Abu Lila AS; Takata H; Kawaguchi Y; Shimizu T; Ando H; Ishima Y; Ishida T
    J Control Release; 2021 Jun; 334():327-334. PubMed ID: 33957196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy.
    Yang Q; Ma Y; Zhao Y; She Z; Wang L; Li J; Wang C; Deng Y
    Int J Nanomedicine; 2013; 8():1257-68. PubMed ID: 23576868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture.
    Lin YC; Chen BM; Tran TTM; Chang TC; Al-Qaisi TS; Roffler SR
    J Control Release; 2023 Feb; 354():354-367. PubMed ID: 36641121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.
    Kozma GT; Mészáros T; Berényi P; Facskó R; Patkó Z; Oláh CZ; Nagy A; Fülöp TG; Glatter KA; Radovits T; Merkely B; Szebeni J
    Vaccine; 2023 Jul; 41(31):4561-4570. PubMed ID: 37330369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine.
    Münter R; Sørensen E; Hasselbalch RB; Christensen E; Nielsen SD; Garred P; Ostrowski SR; Bundgaard H; Iversen KK; Andresen TL; Larsen JB
    Mol Pharm; 2023 Jul; 20(7):3356-3366. PubMed ID: 36952227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum.
    Neun BW; Dobrovolskaia MA
    Methods Mol Biol; 2024; 2789():185-192. PubMed ID: 38507004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEGylated liposomes for diagnosis of polyethylene glycol allergy.
    Perkins GB; Tunbridge MJ; Hurtado PR; Zuiani J; Mhatre S; Yip KH; Le TA; Yuson C; Kette F; Hissaria P
    J Allergy Clin Immunol; 2024 Aug; 154(2):503-507.e1. PubMed ID: 38718949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
    Wang F; Ye X; Wu Y; Wang H; Sheng C; Peng D; Chen W
    J Pharm Sci; 2019 Jan; 108(1):641-651. PubMed ID: 30595169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
    Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
    J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products.
    Ibrahim M; Ramadan E; Elsadek NE; Emam SE; Shimizu T; Ando H; Ishima Y; Elgarhy OH; Sarhan HA; Hussein AK; Ishida T
    J Control Release; 2022 Nov; 351():215-230. PubMed ID: 36165835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.